Am J Transplant, Volume 19, Suppl 3 Archives - Page 42 of 214 - ATC Abstracts

2019 American Transplant Congress
Pneumocystis Prophylaxis in Solid Organ Transplant Recipients at Two Large Transplant Centers from 2015-2016: Why Not Trimethoprim-Sulfamethoxazole?
J. M. Lum¹, V. Athans², I. Echenique³, C. E. Koval¹
¹Infectious Diseases, Cleveland Clinic Floundation, Cleveland, OH, ²Infectious Diseases, University of Pennsylvania, Philadelphia, PA, ³Infectious Diseases, Cleveland Clinic Florida, Weston, FL
*Purpose: Trimethoprim-sulfamethoxazole (T/S) is the drug of choice for Pneumocystis jirovecii pneumonia (PJP) prophylaxis (ppx) after solid organ transplant (SOT). Perceived side effects may lead…
2019 American Transplant Congress
Infectious Complications in 71 Heart Transplant Recipients at King Chulalongkorn Memorial Hospital, Thailand
N. Sangpornsuk¹, J. Wanichwatphibun², A. Ariyachaipanich³, P. Ongcharit⁴, K. Jutivorakool⁵, J. Vanichanan⁵
¹Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand, ²Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand, ³Excellent Center for Organ Transplantation, King Chulalongkorn Memorial Hospital, Bangkok, Thailand, ⁴Cardiothoracic Surgery Unit, Department of Surgery, King Chulalongkorn Memorial Hospital, Bangkok, Thailand, ⁵Division of Infectious Diseases, Department of Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand
*Purpose: Infections have been known as one of the major complication associated with morbidity and mortality especially in the first year following orthotropic heart transplantation…
2019 American Transplant Congress
Fractalkine is Crucial in Ischemia Reperfusion Injury Related to Acute Rejection in an Allogeneic Heart Transplantation Model
T. Kanzawa¹, D. Tokita¹, T. Yamakawa¹, H. Ishigooka¹, H. Fukuda¹, H. Katsumata¹, S. Miyairi¹, R. Ishii¹, T. Hirai¹, K. Saiga¹, M. Okumi¹, T. Imai², K. Tanabe¹
¹Urology, Tokyo Women's Medical University, Tokyo, Japan, ²KAN Research Institute, Kobe, Japan
*Purpose: Ischemia reperfusion injury (IRI) facilitates allograft rejection in renal transplantation recipients (IRI-related rejection). Controlling IRI improves graft survival. Fractalkine (FKN) is an inflammatory chemokine.…
2019 American Transplant Congress
Ceria-Zirconia Nanoparticles as an Enhanced Antioxidant Attenuates Apoptosis of Human Kidney Proximal Tubular Epithelial Cells in Hypoxia
S. Yoon¹, K. Yoon², S. Hong³, S. Yun¹, W. Hwang¹, J. Moon⁴, J. Lee¹, H. Jeon¹
¹Nephrology, Konyang University Hospital, Daejeon, Korea, Republic of, ²Hannam University, Daejeon, Korea, Republic of, ³Chemistry, Hannam University, Daejeon, Korea, Republic of, ⁴General Surgery, Konyang University Hospital, Daejeon, Korea, Republic of
*Purpose: Ischemia/reperfusion injury, resulting from hypoxic damage within a graft, is the leading cause of delayed graft function and graft rejection. Various mechanisms have been…
2019 American Transplant Congress
CMV-Specific Cell-Mediated Immunity Early after Transplantation Discriminates R+ Transplant Patients at Risk of CMV Infection among Different Solid Organ Transplants
M. Jarque¹, A. Cachero², E. Garcia-Romero³, L. Lladó², C. Baliellas², C. Diez³, E. Melilli⁴, J. Fabregat², J. Gonzalez-Costello³, O. Bestard⁴
¹Experimentall Nephrology laboratory, IDIBELL, L'Hospitalet de Llobregat. Barcelona, Spain, ²Liver Transplant Department, Bellvitge University Hospital, L'Hospitalet de Llobregat. Barcelona, Spain, ³Heart Transplant Unit, Cardiology Department, Bellvitge University Hospital, L'Hospitalet de Llobregat. Barcelona, Spain, ⁴Kidney Transplantation Unit, Bellvitge University Hospital- IDIBELL, L'Hospitalet de Llobregat. Barcelona, Spain
*Purpose: While monitoring CMV-specific cell-mediated immunity(CMI) has shown to be effective in predicting the risk of CMV infection, comparisons across different solid organ transplants(SOT) and…
2019 American Transplant Congress
CNV Screening For End-stage Renal Disease
C. E. Fishman, B. Chang, A. Shaked, B. J. Keating
Surgery, University of Pennsylvania, Philadelphia, PA
*Purpose: The prevalence of ESRD in the United States was 2,160.7 cases per one million individuals in 2016, and a primary cause of ESRD was…
2019 American Transplant Congress
Paradoxical Differential Post-transplant Rates Of Change Of Serum Proteins In Pediatric Liver Patients With Evidence For A Novel Sarcopenic-dependent Serum Protein Stimulating Factor
C. M. Schmidt¹, J. Molleston², G. S. Rao², C. A. Kubal¹, S. Atoa¹, R. S. Mangus¹
¹Surgery, Transplant Division, Indiana University, Indianapolis, IN, ²Pediatrics, Division of GI and Hepatology, Indiana University, Indianapolis, IN
*Purpose: Pediatric patients with liver disease suffer from hypoalbuminemia, sarcopenia, and malnutrition. This study aims to quantify differential rates of change (ROC) and post-TX normalization…
2019 American Transplant Congress
Prognostic Value Of Dobutamine Stress Echocardiography In Heart Transplantation Recipients
A. Singhvi, R. Araujo-Gutierrez, M. H. Park, A. Bhimaraj, B. H. Trachtenberg, I. Hussain, A. Guha
Division of Cardiology/ JC Walter Jr. Transplant Center, Houston Methodist Hospital, Houston, TX
*Purpose: Dobutamine stress echocardiography (DSE) carries a class IIa recommendation in the ISHLT guidelines for screening of cardiac allograft vasculopathy (CAV). Positive DSEs have a…
2019 American Transplant Congress
Idarucizumab For The Reversal Of Dabigatran In Patients Undergoing Heart Transplantation
J. Van Keer¹, T. Vanassche¹, W. Droogne¹, S. Rex², F. Rega³, J. Van Cleemput¹, P. Verhamme¹, M. Naesens⁴
¹Cardiology, University Hospitals Leuven, Leuven, Belgium, ²Anesthesiology, University Hospitals Leuven, Leuven, Belgium, ³Cardiovascular Surgery, University Hospitals Leuven, Leuven, Belgium, ⁴Nephrology, University Hospitals Leuven, Leuven, Belgium
*Purpose: Atrial fibrillation is common among patients with advanced heart failure who are listed for transplantation. Idarucizumab is a monoclonal antibody fragment that was developed…
2019 American Transplant Congress
Extracorporeal Photopheresis for Specific Immune Tolerance Responses in Heart Transplant Recipients
M. J. Barten¹, K. Klaeske², J. Wittke², M. Borger², J. Garbade², S. Lehmann³, H. Reichenspurner¹, M. Dieterlen²
¹Cardiovascular Surgery, University Heart Center, Hamburg, Germany, ²Cardiac Surgery, University Heart Center Leipzig, Leipzig, Germany, ³Cardiacr Surgery, University Heart Center Leipzig, Leipzig, Germany
*Purpose: Extracorporeal photopheresis (ECP) treatment following heart transplantation (HTx) may induce transplant tolerance. A monitoring tool for successful ECP treatment would allow determination of patient-specific…